Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds CL King Downgrades G-III Apparel Group to Neutral

CL King Downgrades G-III Apparel Group to Neutral

CL King analyst Steven Marotta downgrades G-III Apparel Group (NASDAQ:GIII) from Buy to Neutral.

byBenzinga Newsdesk

December 1, 2022

1 minute read

CL King analyst Steven Marotta downgrades G-III Apparel Group (NASDAQ:GIII) from Buy to Neutral.

After Elon Musk’s Twitter Blue Chaos, Platform Now ‘Rolling Out’ New Feature To Enable Companies Authenticate Users

By Ananya Gairola

November 14, 2:50 AM

Tesla Inc. (NASDAQ: TSLA) CEO and now Twitter chief Elon Musk has announced that the microblogging site will soon enable organizations to manage affiliated accounts.

LLY

Legal
News

Russia Seeks $220M In Unpaid Taxes From Exxon

By Charles Gross

January 31, 6:55 AM

-Reuters Citing Russia's Tass, Interfax

SPY

Top 5 Health Care Stocks That May Crash This Month

By Avi Kapoor

January 22, 8:34 AM

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

CLSD

Incannex Receives HREC Approval For Phase 2 Clinical Trial Assessing IHL-675A For Use In Treatment Of Pain And Function In Rheumatoid Arthritis

By Happy Mohamed

July 13, 8:15 AM

Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain and

IXHL

CL King Downgrades G-III Apparel Group to Neutral

Related Posts

After Elon Musk’s Twitter Blue Chaos, Platform Now ‘Rolling Out’ New Feature To Enable Companies Authenticate Users

Russia Seeks $220M In Unpaid Taxes From Exxon

Top 5 Health Care Stocks That May Crash This Month

Incannex Receives HREC Approval For Phase 2 Clinical Trial Assessing IHL-675A For Use In Treatment Of Pain And Function In Rheumatoid Arthritis